Plus Therapeutics: Prepare For The Imminent Dilution [Seeking Alpha]
PLUS THERAPEUTICS, Inc. (PSTV)
Company Research
Source: Seeking Alpha
Plus Therapeutics: Prepare For The Imminent Dilution Summary Plus Therapeutics rose 272% last Friday after releasing its Q2 results, with nothing in that report justifying that kind of move. PSTV has preferred shares and warrants outstanding with conversion rates that were recently reduced from $39.93 to $7.50 per common share. PSTV is quickly running out of cash and is subject to a term loan covenant. Expect an imminent announcement of a financing. Plus Therapeutics, Inc. ( While the 272% move looks nice on the daily chart, the five year chart of Plus/Cytori tells investors all they need to know about PSTV's past and where it is likely to head in the very near future: Cytori had problems commercializing its stem cell therapies and relied heavily on extremely dilutive financings in the past, including notorious nanocap financier Lincoln Park Capital, which I have written about several times before Expect dilution at $7.50 from previously existing convertible securities PSTV moved as m
Show less
Read more
Impact Snapshot
Event Time:
PSTV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PSTV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PSTV alerts
High impacting PLUS THERAPEUTICS, Inc. news events
Weekly update
A roundup of the hottest topics
PSTV
News
- Plus Therapeutics Announces Private Placement Financing of up to $18 Million [Yahoo! Finance]Yahoo! Finance
- Plus Therapeutics Announces Private Placement Financing of up to $18 MillionGlobeNewswire
- Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense [Yahoo! Finance]Yahoo! Finance
- Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense [Yahoo! Finance]Yahoo! Finance
- Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of DefenseGlobeNewswire
PSTV
Earnings
- 10/31/23 - Miss
PSTV
Sec Filings
- 3/14/24 - Form 8-K
- 3/13/24 - Form 8-K
- 3/8/24 - Form S-1/A
- PSTV's page on the SEC website